NB-UVB ljós geta gefið langtíma bata á psoriasis

NB-UVB Irradiation May Achieve Effectively Treat Psoriasis Vulgaris.
MedWire (11/19, Piper) reported that, according to a study published online in the Journal of Dermatology, "narrowband ultraviolet B light (NB-UVB) irradiation five days a week for four weeks is an effective treatment option for psoriasis vulgaris" that may even bring about a long-term remission. After treating "52 patients with a five-day/week protocol of NB-UVB light irradiation plus topical vitamin D ointment application for one month and monitored them for at least 12 months," researchers found that nearly "half of the patients had a remission period longer than one year, and 75% of the patients had a remission period longer than six months."

Rannsóknir benda til að krem sem er hægt að kaupa án lyfseðils hafi góð áhrif á hrukkur

Study indicates UK over-the-counter beauty serum may reduce fine wrinkles.

Following a

BBC News

story, the UK's

Times

(4/29, Rose) reported that, according to a

study

published online Apr. 28 in the British Journal of Dermatology, Boots "No. 7 Protect & Perfect beauty serum" has been "clinically proven to reduce fine wrinkles and improve the appearance of weathered skin." For the study, "dermatologists at the University of Manchester carried out a trial on 60 volunteers with signs of sun-damaged skin and found that the cream...could help reduce the most common signs of aging." In fact, "70 percent of people who used the cream for a year had significantly fewer wrinkles compared with volunteers using a placebo." The Times quoted Nina Goad, of the British Association of Dermatologists, as saying, "Approximately one in five people using the cream will get something extra for their money over plain moisturizers."
        "Few over-the-counter 'anti-aging' products have been subjected to a rigorous scientific trial to prove their effectiveness," said study leader Chris Griffiths, a dermatology professor at the University of Manchester, the UK's

Mirror

(4/29) reported.
        According to

Retail Week

(4/29, Creevy), "The study...found the cream stimulated production of fibrillin in the skin. Over a 12-month period, these structural effects in the skin are sustained." The product is now on sale in the United Kingdom and is "priced at £19.75 [approximately $29.24] for 30ml."

Tíðindamaður Húðlæknastöðvarinnar var nýlega staddur í Bretlandi og keypti nokkrar krukkur af kreminu góða á 3 fyrir 2 tilboði. (20 pund fyrir 3 krukkur). Enn er þó of fljótt að segja fyrir um árangurinn, en ef eitthvað er að marka háskólann í Manchester ætti hann ekki að láta á sér standa. Ekki sakar að geta þess að forstöðumaður rannsóknarinnar, prófessor Griffiths var eitt í framhaldsnámi á Landspítalanum hjá Helga Valdimarssyni prófessor í ónæmisfræði.

Húðlæknar veita ráð um húðvernd

Dermatologists provide tips on skin care.

The UK's

Daily Mail

(4/19, Penman) asked some of "leading dermatologists...what they put on their skin to keep it looking fresh and young." The dermatologists recommended focusing "on cleaning [the] skin without sapping away its natural moisture." Those with dry skin should avoid "over-washing." The dermatologists also suggested using moisturizers that "reinforce the skin's naturally protective oily layer and lock in moisture." They were "united in endorsing sunblocks," recommending products that are "at least factor 15 and...efficient at screening out UVA rays." As for "anti-wrinkle ingredients touted by the cosmetics industry," dermatologist Dr. Sam Bunting said, "They are designed to sit on the surface of the skin -- not penetrate it -- so they don't work. It's as simple as that." Dr. Sue Mayou, spokeswoman for the British Skin Foundation, explained that if cosmetic companies proved categorically that such products did work, then the "products would have to be licensed as medicines," and would have to "be available only on prescription."

Skoðið tengilin hér að ofan. Þar seru sett fram ýmis praktísk ráð varðandi val á kremum fyrir almenna húðhirðu.

Daivobet bætir naglpsoriasis

Calcipotriol plus betamethasone ointment improves symptoms of nail psoriasis, researchers say.

MedWire

(4/3, McDermid) reports that, according to a

study

published online in the journal Dermatology, "a two-compound ointment containing calcipotriol and betamethasone improves the symptoms of patients with nail psoriasis." For the study, researchers from the University of Athens Medical School in Greece "recruited 22 psoriasis patients with mild dermatological symptoms and 114 involved nails," then "treated them with a two-compound calcipotriol plus betamethasone ointment for 12 weeks." Participants "were instructed to apply the ointment at bedtime and to avoid washing their hands until the next morning." The investigators said that "this treatment regimen resulted in a 72 percent reduction in average Nail Psoriasis Severity Index (NAPSI) scores -- from 5.8 at baseline to 1.6 at 12 weeks." In particular, "the ointment was most effective for reducing hyperkeratosis...and onycholysis," and "also caused moderate improvements in oil drops and slight improvements in pitting."
       

Study indicates calcipotriol, betamethasone dipropionate ointment may be more effective for treatment of scalp psoriasis.

MedWire

(4/3, Piper) reports that, according to a

study

published online in the British Journal of Dermatology, a "once-daily combination" regimen of "calcipotriol plus betamethasone dipropionate" appears to be "significantly more effective and better tolerated than twice-daily calcipotriol scalp solution alone for the treatment of scalp psoriasis." For the study, researchers from Denmark's Aarhus University Hospital compared the combination formulation's "clinical efficacy and safety" against "twice-daily calcipotriol, for scalp psoriasis," and found that "significantly more of the 207 patients receiving the two-compound solution reported relief from itching and were 'clear' of psoriasis or had 'minimal disease' after eight weeks of treatment than the 105 receiving calcipotriol, at 68.6...versus 31.4 percent." Moreover, "improvement was rapid with a significant difference evident as early as week two." The authors noted, however, "that maintenance therapy with the two-compound scalp formulation may be necessary after observing a relapse rate of 54.1 percent."

Bretar vilja þrengja reglugerðir vegna ljósbekkja eftir að ung stúlka brennur illa

Sunbed campaign targets schools

Schoolchildren are being given the chance to quiz skin cancer experts and victims over the dangers of sunbeds. The Sunsmart campaign was launched at Bishop Gore Comprehensive in Swansea and will visit other schools in Wales. It follows the case of Kirsty McRae who suffered 70% burns on her body and ended up on a drip in hospital after using a coin-operated sunbed in Barry.........

Calls to staff all tanning salons

Calls for unstaffed tanning salons to be banned after a 14-year-old burnt over 70% of her body have been made by dermatologists and politicians. A health and safety inquiry is underway into Kirsty McRae's 19-minute use of the salon in Barry, Vale of Glamorgan. Swansea East MP Sian James said the case was the "tip of the iceberg" of youngsters using such salons. Salon owner James Hadley said he actively tried to discourage under-16s from using his shop.Kirsty, from Barry Island, Vale of Glamorgan, said she took full responsibility for using the unstaffed ..........

Rannsóknir benda til að unglingabólur séu tengdar x-litningnum

Study indicates risk for acne may be linked with X chromosome.

MedWire

(3/27, Wilkinson) reported that, according to a study published in the Journal of Investigative Dermatology, "the risk for acne may be linked with the X chromosome." For the study, researchers from the Dessau Medical Center in Germany examined "risk factors for acne vulgaris among 1,002 Iranian pupils in Tehran, of whom 499 were boys and 503 were girls. The mean age of participants in the cross-sectional study was 16 years." The team found that the "risk for suffering moderate-to-severe acne increased with the number of affected immediate members of the family." Notably, "the mother's acne history was more important in determining its severity than the father's," with both being "more influential in determining acne severity than brothers or sisters." The authors also found that "moderate-to-severe acne was...associated with the premenstrual phase, mental stress, and eating sweet and oily foods, but not with gender, spicy foods, or smoking overall."

Sólbruni og fjölskyldusaga auka líkur á rósroða

Study implicates sunburn, family history in rosacea.

HealthDay

(3/10, McKeever) reported that, according to a study presented at the annual meeting of the American Academy of Dermatology, "people with the reddening skin condition rosacea tend to have a family history of the disease and a personal history of sunburns." Researchers from Harvard Medical School found that, in a "study of 130 people, half with moderate to severe rosacea and half without, 34 percent of those with the disease reported having a relative who also had the skin disorder, whereas only about 10 percent of those without the disease had it in their family." In addition, the team "found that 44 percent of people with rosacea reported having had blistering sunburns at some time, compared with just more than five percent of the others." The authors recommended that "people who have a family history of rosacea," particularly "children...regularly use broad-spectrum sunscreen and use other sun protection measures."